Pneumococcal pneumonia: Differences according to blood culture results

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Capelastegui, Alberto ^a   Zalacain, Rafael ^b   Bilbao, Amaia ^c   Egurrola, Mikel ^a   Iturriaga, Luis Alberto R ^b   Quintana, Jose M ^a   Gomez, Ainhoa ^b   Esteban, Cristobal ^a   España, Pedro P ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

Author keywords

Bacteremia; Pneumococcal pneumonia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; LEVOFLOXACIN; MACROLIDE; PREDNISONE; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOST; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; SEPTIC SHOCK; SPAIN; STREPTOCOCCUS PNEUMONIA; TREATMENT FAILURE; COMPLICATION; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MICROBIOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BACTEREMIA; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 84905729626     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-128     Document Type: Article

References (37)

1. Berjohn CM, Fishman NO, Joffe MM, Edelstein PH, Metalay JP. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia. Medicine 2008, 87:160-166.
2. Kalin M, Ortqvist A, Almela M, Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA. Prospective study of prognostic factors in Community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 2000, 182:840-847.
3. Mufson MA, Stanek RJ. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997. Am J Med 1999, 107(Suppl):34S-43S.
4. Garcia-Vidal C, Ardanuy C, Tubau F, Garcia-Vidal C, Ardanuy C, Tubau F, Viasus D, Dorca J, Liñares J, Gudiol F, Carratala` J. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax 2010, 65:77-81.
5. Watanakunakom C, Bailey TA. Adult bacteremic pneumococcal pneumonia in a community teaching hospital.... 1992-1996: a detailed analysis of 108 cases. Arch Intern Med 1997, 157:1965-1971.
6. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA 1996, 275:194-198.
7. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ, . ACCP/SCCM Consensus Conference Committee Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest 1992, 101:1644-1655. ACCP/SCCM Consensus Conference Committee.
8. Alberti C, Brun-Buisson C, Chevret S, Antonelli M, Goodman SV, Martin C, Moreno R, Ochagavia AR, Palazzo M, Werdan K, Le Gall JR, . European Sepsis Study Group Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med 2005, 171:461-468. European Sepsis Study Group.
9. Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, Smithies M, Thomas O, Artigas A, Le Gall JR, . European Sepsis Group Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003, 168:77-84. European Sepsis Group.
10. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia. When does it happen, and do systemic inflammatory response syndrome criteria help predict course?. Chest 2006, 129:968-978.
11. Watanakunakorn C, Greifenstein A, Stroh K, Jarjoura DG, Blend D, Cugino A, Ognibene AJ. Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 1993, 103:1152-1156.
12. Torres JM, Cardenas O, Vasquez A, Schlossberg D. Streptococcus penumoniae bacteremia in a community hospital. Chest 1998, 113:387-390.
13. Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 1974, 134:505-510.
14. Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, Chang HH, Kim SW, Lee H, Kim YS, Oh WS, Peck KR, Chongthaleong A, Lalitha MK, Perera J, Yee TT, Jamal F, Kamarulzaman A, Carlos CC, So T, . Asian Network for Surveillance of Resistant Pathogens Study Group Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian network for surveillance of resistant pathogens. Clin Infect Dis 2004, 38:1570-1578. Asian Network for Surveillance of Resistant Pathogens Study Group.
15. Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP, . International Pneumococcal Study Group An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003, 37:230-237. International Pneumococcal Study Group.
16. Moroney JF, Fiore AE, Harrison LH, Patterson JE, Farley MM, Jorgensen JH, Phelan M, Facklam RR, Cetron MS, Breiman RF, Kolczak M, Schuchat A. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001, 33:797-805.
17. Bohte R, van Furth R, van den Broek P. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995, 50:543-547.
18. Musher DM, Alexandraki I, Graviss EA, Yanbeiy N, Eid A, Inderias LA, Phan HM, Solomon E. Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study. Medicine 2000, 79:210-221.
19. Brandenburg JA, Marrie TJ, Coley CM, Singer DE, Obrosky DS, Kapoor WN, Fine MJ. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. J Gen Intern Med 2000, 15:638-646.
20. Jover F, Cuadrado JM, Andreu L, Marti´nez S, Cañizares R, de la Tabla VO, Martin C, Roig P, Merino J. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Eur J Intern Med 2008, 19:15-21.
21. Garcia-Vidal C, Ferna´ndez-Sabe´ N, Carratala` J, Di´az V, Verdaguer R, Dorca J, Manresa F, Gudiol F. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 2008, 32:733-739.
22. Lin SH, Lai CC, Tan CK, Liao WH, Hsueh PR. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Epidemiol Infect 2011, 139:1307-1316.
23. Marrie TJ, Low DE, De Carolis E, . and the Canadian Community-Acquired Pneumonia Investigators A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology -Results from a Canadian multicentre study. Can Respir J 2003, 7:368-374. and the Canadian Community-Acquired Pneumonia Investigators.
24. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia: a metaanalysis. JAMA 1996, 275(2):134-141.
25. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
26. Mene´ndez R, Torres A, Aspa J, Capelastegui A, Prat C, Rodri´guez de Castro F, . Sociedad Española de Neumologi´a y Cirugi´a Tora´cica Community-acquired pneumonia. New guidelines of the Spanish Society of Pulmonary and Thoracic Surgery (SEPAR). Arch Bronconeumol 2010, 46:543-558. Sociedad Española de Neumologi´a y Cirugi´a Tora´cica.
27. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, . SCCM/ESICM/ACCP/ATS/SIS SCCM/ESICM/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. SCCM/ESICM/ACCP/ATS/SIS.
28. Mene´ndez R, Torres A, Zalacai´n R, Aspa J, Marti´n Villasclaras JJ, Borderi´as L, Beni´tez Moya JM, Ruiz-Manzano J, Rodri´guez de Castro F, Blanquer J, Pe´rez D, Puzo C, Sa´nchez Gasco´n F, Gallardo J, Alvarez C, Molinos L, . Neumofail Group Risk factors of treatment failure in community-acquired pneumonia: implications for disease outcome. Thorax 2004, 59:960-965. Neumofail Group.
29. Kaplan V, Angus DC, Griffin MF, Clermont G, Watson RS, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002, 165:766-772.
30. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. Gender differences in human sepsis. Arch Surg 1998, 133:1200-1205.
31. Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med 2007, 101:1845-1863.
32. Warren JL, Bacon E, Harris T, McBean AM, Foley DJ, Phillips C. The burden and outcomes associated with dehydration among US elderly, 1991. Am J Public Health 1994, 84:1265-1269.
33. Bordo´n J, Peyrani P, Brock GN, Blasi F, Rello J, File T, Ramirez J, . CAPO Study Group The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia. Result from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Chest 2008, 133(3):618-624. CAPO Study Group.
34. Lisboa T, Blot S, Waterer GW, Canalis E, de Mendoza D, Rodriguez A, Rello J. Community-Acquired Pneumonia Intensive Care Units Study Investigators. Radiologic progression of pulmonary infiltrates predicts a worse prognosis in severe community-acquired pneumonia than bacteremia. Chest 2009, 135:165-172.
35. Marti´nez JA, Horcajada JP, Almela M, Marco F, Soriano A, Garci´a E, Marco MA, Torres A, Mensa J. Addition of a macrolide to a B-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003, 36:389-395.
36. Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001, 161:1837-1842.
37. File TM, Mandell LA. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?. Clin Infect Dis 2003, 36:396-398.